The Role of Single Nucleotide Polymorphisms of Monoamine Oxidase B, Dopamine D2 Receptor, and DOPA Decarboxylase Receptors Among Patients Treated for Parkinson's Disease

被引：7

作者：

Zapala, Barbara ^{[1
]}

Stefura, Tomasz ^{[2
]}

Piwowar, Monika ^{[3
]}

Czekalska, Sylwia ^{[4
]}

Zawada, Magdalena ^{[4
]}

Hadasik, Maria ^{[1
]}

Solnica, Bogdan ^{[1
]}

Rudzinska-Bar, Monika ^{[5
]}

机构：

[1] Jagiellonian Univ Med Coll, Dept Clin Biochem, Krakow, Poland

[2] Jagiellonian Univ Med Coll, Krakow, Poland

[3] Jagiellonian Univ Med Coll, Dept Bioinformat & Telemed, Krakow, Poland

[4] Univ Hosp, Dept Hematol Diagnost & Genet, Krakow, Poland

[5] Andrzej Frycz Modrzewski Krakow Univ, Krakow, Poland

来源：

JOURNAL OF MOLECULAR NEUROSCIENCE | 2022年 / 72卷 / 04期

关键词：

Parkinson's disease; Single nucleotide polymorphisms; Receptors; GENE VARIANTS; DRD2; SUSCEPTIBILITY; DYSKINESIAS; ASSOCIATION; RISK;

D O I：

10.1007/s12031-022-01966-3

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

This study aimed to investigate the association between selected variants of genes related to dopamine metabolism pathways and the risk of and progression of Parkinson's disease (PD). This prospective cohort study was conducted in one academic teaching hospital. The study was conducted on 126 patients diagnosed with idiopathic Parkinson's disease. Blood samples were collected to conduct a genotyping of MAOB, DRD1, DRD2, and DDC genes. Genotype and allele frequencies of MAOB (rs1799836) variants were not associated with the course of PD. Genotype and allele frequencies of DRD2 (rs2283265) variants were associated with risk of dementia (p = 0.001) and resulted in parts II and III of the UPDRS scale (p = 0.001). Genotype and allele frequencies of DRD2 (rs1076560) variants were associated with risk of dementia (p = 0.001) and resulted in parts II and III of the UPDRS scale (p = 0.001). Genotype and allele frequencies of DDC (rs921451) variants were not associated with the course of PD.

引用

页码：812 / 819

页数：8

共 31 条

[1] Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency [J].

Brun, L. ;

Ngu, L. H. ;

Keng, W. T. ;

Ch'ng, G. S. ;

Choy, Y. S. ;

Hwu, W. L. ;

Lee, W. T. ;

Willemsen, M. A. A. P. ;

Verbeek, M. M. ;

Wassenberg, T. ;

Regal, L. ;

Orcesi, S. ;

Tonduti, D. ;

Accorsi, P. ;

Testard, H. ;

Abdenur, J. E. ;

Tay, S. ;

Allen, G. F. ;

Heales, S. ;

Kern, I. ;

Kato, M. ;

Burlina, A. ;

Manegold, C. ;

Hoffmann, G. F. ;

Blau, N. .

NEUROLOGY, 2010, 75 (01) :64-71

[2] Parkinson's Disease: From Pathogenesis to Pharmacogenomics [J].

Cacabelos, Ramon .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03)

[3] Pharmacological Treatment of Parkinson Disease A Review [J].

Connolly, Barbara S. ;

Lang, Anthony E. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (16) :1670-1683

[4] Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease [J].

Devos, David ;

Lejeune, Stephanie ;

Cormier-Dequaire, Florence ;

Tahiri, Khadija ;

Charbonnier-Beaupel, Fanny ;

Rouaix, Nathalie ;

Duhamel, Alain ;

Sablonniere, Bernard ;

Bonnet, Anne-Marie ;

Bonnet, Cecilia ;

Zahr, Noel ;

Costentin, Jean ;

Vidailhet, Marie ;

Corvol, Jean-Christophe .

PARKINSONISM & RELATED DISORDERS, 2014, 20 (02) :170-175

[5] Gradient of Expression of Dopamine D2 Receptors Along the Dorso-Ventral Axis of the Hippocampus [J].

Dubovyk, Valentyna ;

Manahan-Vaughan, Denise .

FRONTIERS IN SYNAPTIC NEUROSCIENCE, 2019, 11

[6] Association of dopamine gene variants, emotion dysregulation and ADHD in autism spectrum disorder [J].

Gadow, Kenneth D. ;

Pinsonneault, Julia K. ;

Perlman, Greg ;

Sadee, Wolfgang .

RESEARCH IN DEVELOPMENTAL DISABILITIES, 2014, 35 (07) :1658-1665

[7] Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan [J].

Glatt, S. J. ;

Faraone, S. V. ;

Lasky-Su, J. A. ;

Kanazawa, T. ;

Hwu, H-G ;

Tsuang, M. T. .

MOLECULAR PSYCHIATRY, 2009, 14 (09) :885-893

[8] Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies [J].

Gluskin, B. S. ;

Mickey, B. J. .

TRANSLATIONAL PSYCHIATRY, 2016, 6 :e747-e747

[9]

Hao H, 2015, J MED GENET, V32, P1, DOI [10.3760/cma.j.issn.1003-9406.2015.01.001, DOI 10.3760/CMA.J.ISSN.1003-9406.2015.01.001]

[10] L-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism [J].

Kaiser, R ;

Hofer, A ;

Grapengiesser, A ;

Gasser, T ;

Kupsch, A ;

Roots, I ;

Brockmöller, J .

NEUROLOGY, 2003, 60 (11) :1750-1755

← 1 2 3 4 →